YAP1 and heart disorder: These findings not only enhance our understanding of the molecular mechanisms underlying pressure overload–induced cardiac dysfunction but also pave the way for the development of novel therapeutic strategies targeting the Wnt5a-YAP signaling axis in cardiac diseases associated with pressure overload.